بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
progress decrease » progressive decrease (توسيع البحث), problems decreased (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
progress decrease » progressive decrease (توسيع البحث), problems decreased (توسيع البحث)
-
541
-
542
Details of intervention by groups.
منشور في 2025"…<div><p>Background</p><p>Open defecation (OD) remains a significant public health challenge in India, contributing to adverse child health outcomes. …"
-
543
Treatment impacts on hygiene behavior.
منشور في 2025"…<div><p>Background</p><p>Open defecation (OD) remains a significant public health challenge in India, contributing to adverse child health outcomes. …"
-
544
-
545
Calibration of standards.
منشور في 2024"…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.</p></div>…"
-
546
Appearance of standards under UV 365 nm.
منشور في 2024"…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.</p></div>…"
-
547
HPLC-Chromatogram of methanol fraction.
منشور في 2024"…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.</p></div>…"
-
548
Effects of <i>B</i>.<i>erecta</i> on kidney profile test.
منشور في 2024"…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.</p></div>…"
-
549
Effects of <i>B</i>.<i>erecta</i> on Morris water maze test.
منشور في 2024"…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.</p></div>…"
-
550
Effects of <i>B</i>.<i>erecta</i> on liver profile test.
منشور في 2024"…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.</p></div>…"
-
551
mRNA-specific primers of genes.
منشور في 2025"…<div><p>Background</p><p>Tryptophan metabolism is involved in the progression and immune response of multiple diseases. …"
-
552
Basic information of retrieved datasets.
منشور في 2025"…<div><p>Background</p><p>Tryptophan metabolism is involved in the progression and immune response of multiple diseases. …"
-
553
POriginal blots.
منشور في 2025"…<div><p>Background</p><p>Tryptophan metabolism is involved in the progression and immune response of multiple diseases. …"
-
554
PTable S4 Expression validation of CYP1B1.
منشور في 2025"…<div><p>Background</p><p>Tryptophan metabolism is involved in the progression and immune response of multiple diseases. …"
-
555
PTable S2 Differentially expressed genes.
منشور في 2025"…<div><p>Background</p><p>Tryptophan metabolism is involved in the progression and immune response of multiple diseases. …"
-
556
PTable S5 Markers of each cell cluster.
منشور في 2025"…<div><p>Background</p><p>Tryptophan metabolism is involved in the progression and immune response of multiple diseases. …"
-
557
-
558
Participant flow (CONSORT diagram).
منشور في 2024"…Peak anti-<i>Na</i>-GST-1 IgG levels were observed between 2 and 4 weeks following the third dose, regardless of <i>Na</i>-GST-1 formulation. IgG levels decreased but remained significantly above baseline in all groups by day 290, at which point all participants (20 of 20 evaluable participants) still had detectable IgG. …"
-
559
Descriptive data for the pBT-child dyads.
منشور في 2025"…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …"
-
560
CFQL-2 descriptive statistics.
منشور في 2025"…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …"